APA (7th ed.) Citation

L, A., R, R., A, W., H, M., S, L., G, A., & R, L. (2026). Ascending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human. Psychopharmacology, 243(3), 565. https://doi.org/10.1007/s00213-025-06861-4

Chicago Style (17th ed.) Citation

L, Appel, Risinger R, Wall A, Murck H, Liu S, Antoni G, and Lane R. "Ascending Single-dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CSTI-500, a Novel Monoamine Triple Reuptake Inhibitor, First-in-human." Psychopharmacology 243, no. 3 (2026): 565. https://doi.org/10.1007/s00213-025-06861-4.

MLA (9th ed.) Citation

L, Appel, et al. "Ascending Single-dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CSTI-500, a Novel Monoamine Triple Reuptake Inhibitor, First-in-human." Psychopharmacology, vol. 243, no. 3, 2026, p. 565, https://doi.org/10.1007/s00213-025-06861-4.